Schedule 13D ownership disclosure

REVIVA PHARMACEUTCLS HLDGS I

Security class unavailable · CUSIP: 76152G100

Event date: 2023-11-20

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,885,678
Percent of class
10.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001437749-24-004592
Form type
SC 13D/A
Filer
Bhat Laxminarayan
CIK
CIK 1818245
Filed
Feb 16, 2024
Reporting period
Nov 20, 2023
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub